Coburger C - Search Results

1

Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells.

Lage H, Duarte N, Coburger C, Hilgeroth A, Ferreira MJ. Lage H, et al. Among authors: coburger c. Phytomedicine. 2010 May;17(6):441-8. doi: 10.1016/j.phymed.2009.07.009. Epub 2009 Aug 13. Phytomedicine. 2010. PMID: 19682879

2

Novel insight in structure-activity relationship and bioanalysis of P-glycoprotein targeting highly potent tetrakishydroxymethyl substituted 3,9-diazatetraasteranes.

Coburger C, Wollmann J, Baumert C, Krug M, Molnár J, Lage H, Hilgeroth A. Coburger C, et al. J Med Chem. 2008 Sep 25;51(18):5871-4. doi: 10.1021/jm800480y. Epub 2008 Aug 21. J Med Chem. 2008. PMID: 18714979

3

Impact of novel MDR modulators on human cancer cells: reversal activities and induction studies.

Coburger C, Lage H, Molnár J, Hilgeroth A. Coburger C, et al. Pharm Res. 2009 Jan;26(1):182-8. doi: 10.1007/s11095-008-9736-7. Epub 2008 Oct 30. Pharm Res. 2009. PMID: 18972190

4

Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.

Coburger C, Wollmann J, Krug M, Baumert C, Seifert M, Molnár J, Lage H, Hilgeroth A. Coburger C, et al. Bioorg Med Chem. 2010 Jul 15;18(14):4983-90. doi: 10.1016/j.bmc.2010.06.004. Epub 2010 Jun 9. Bioorg Med Chem. 2010. PMID: 20598550

5

Multidrug resistance reversal properties and cytotoxic evaluation of representatives of a novel class of HIV-1 protease inhibitors.

Coburger C, Lage H, Molnár J, Langner A, Hilgeroth A. Coburger C, et al. J Pharm Pharmacol. 2010 Dec;62(12):1704-10. doi: 10.1111/j.2042-7158.2010.01144.x. Epub 2010 Oct 4. J Pharm Pharmacol. 2010. PMID: 21054396

6

The impact of the induction of multidrug resistance transporters in therapies by used drugs: recent studies.

Hilgeroth A, Hemmer M, Coburger C. Hilgeroth A, et al. Among authors: coburger c. Mini Rev Med Chem. 2012 Oct;12(11):1127-34. doi: 10.2174/138955712802762130. Mini Rev Med Chem. 2012. PMID: 22512559 Review.

7

Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors.

Voigt B, Coburger C, Monár J, Hilgeroth A. Voigt B, et al. Among authors: coburger c. Bioorg Med Chem. 2007 Aug 1;15(15):5110-3. doi: 10.1016/j.bmc.2007.05.036. Epub 2007 May 18. Bioorg Med Chem. 2007. PMID: 17533131

8

Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: first structure-activity relationships.

Krawczyk S, Otto M, Otto A, Coburger C, Krug M, Seifert M, Tell V, Molnár J, Hilgeroth A. Krawczyk S, et al. Among authors: coburger c. Bioorg Med Chem. 2011 Nov 1;19(21):6309-15. doi: 10.1016/j.bmc.2011.09.005. Epub 2011 Sep 10. Bioorg Med Chem. 2011. PMID: 21964185

9

Novel structurally varied N-alkyl 1,4-dihydropyridines as ABCB1 inhibitors: structure-activity relationships, biological activity and first bioanalytical evaluation.

Hilgeroth A, Baumert C, Coburger C, Seifert M, Krawczyk S, Hempel C, Neubauer F, Krug M, Molnár J, Lage H. Hilgeroth A, et al. Among authors: coburger c. Med Chem. 2013 Jun 1;9(4):487-93. doi: 10.2174/1573406411309040002. Med Chem. 2013. PMID: 23167942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters